(Q36135987)

12 August 2017

Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment (English)

1 reference

12 August 2017

Håkansson A

1

1 reference

12 August 2017

Gustafsson B

series ordinal

2

1 reference

12 August 2017

Krysander L

series ordinal

3

1 reference

12 August 2017

Håkansson L

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

5

1 reference

12 August 2017

670-676

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1996.420

12 August 2017

0 references

cites work

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Histologic regression in malignant melanoma: an interobserver concordance study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Human tumor-infiltrating lymphocytes: a marker of host response.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term responders

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Current therapy for malignant melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Spontaneous regression of metastatic melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Immunocytochemical Analysis of the Cellular Infiltrate in Primary Regressing and Non-Regressing Malignant Melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Immunologic Effects of Interferon

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Biologic Effects of Interferons

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Spontaneous regression of melanoma

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074699

Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases

2 July 2018

1 reference

12 December 2020

Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Thin malignant melanomas with regression and metastases

1 reference

12 December 2020

Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors

1 reference

12 December 2020

1 reference

12 December 2020

Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi

1 reference

12 December 2020

In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin

1 reference

12 December 2020

Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mito

1 reference

12 December 2020

Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen

1 reference

12 December 2020

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.420

1 reference

12 August 2017

1 reference

12 August 2017

1 reference